The crucial role of vascular permeability factor/vascular endothelial growth factor in angiogenesis: a historical review
- PMID: 15667531
- DOI: 10.1111/j.1365-2141.2004.05291.x
The crucial role of vascular permeability factor/vascular endothelial growth factor in angiogenesis: a historical review
Abstract
Angiogenesis is a biological process by which new capillaries are formed and it occurs in many physiological and pathological conditions. It is controlled by the net balance between molecules that have positive and negative regulatory activity and this concept had led to the notion of the 'angiogenic switch', depending on an increased production of one or more of the positive regulators of angiogenesis. Numerous inducers of angiogenesis have been identified and this review offers a historical account of the relevant literature concerning the discovery of one of the best characterized angiogenic factors, namely vascular endothelial growth factor (VEGF)/vascular permeability factor. Moreover, different strategies, designed to stimulate and to inhibit VEGF production in the context of several potential therapeutical implications, are discussed.
Similar articles
-
Angiogenesis: basic and clinical aspects.Ital J Anat Embryol. 2003 Jan-Mar;108(1):1-24. Ital J Anat Embryol. 2003. PMID: 12737512 Review.
-
[Targeting angiogenesis in oncology].Pathol Biol (Paris). 2006 May;54(4):199-205. doi: 10.1016/j.patbio.2004.11.003. Epub 2005 Jan 20. Pathol Biol (Paris). 2006. PMID: 16753494 Review. French.
-
Expression of vascular endothelial growth factor (VEGF) and VEGF receptors in tumor angiogenesis and malignancies.Integr Cancer Ther. 2005 Dec;4(4):315-21. doi: 10.1177/1534735405282557. Integr Cancer Ther. 2005. PMID: 16282508 Review.
-
Vascular endothelial growth factor.Arterioscler Thromb Vasc Biol. 2009 Jun;29(6):789-91. doi: 10.1161/ATVBAHA.108.179663. Epub 2009 Jan 22. Arterioscler Thromb Vasc Biol. 2009. PMID: 19164810 Review.
-
[Neoplasms and angiogenesis].Pol Merkur Lekarski. 2002 Sep;13(75):225-8. Pol Merkur Lekarski. 2002. PMID: 12474576 Review. Polish.
Cited by
-
Bone marrow angiogenesis and progression in multiple myeloma.Am J Blood Res. 2011;1(1):76-89. Epub 2011 Jun 8. Am J Blood Res. 2011. PMID: 22432068 Free PMC article.
-
Angiogenesis and melanoma.Cancers (Basel). 2010 Feb 25;2(1):114-32. doi: 10.3390/cancers2010114. Cancers (Basel). 2010. PMID: 24281035 Free PMC article.
-
Dose effect of dual delivery of vascular endothelial growth factor and bone morphogenetic protein-2 on bone regeneration in a rat critical-size defect model.Tissue Eng Part A. 2009 Sep;15(9):2347-62. doi: 10.1089/ten.tea.2008.0510. Tissue Eng Part A. 2009. PMID: 19249918 Free PMC article.
-
The role of NOS2A -954G/C and vascular endothelial growth factor +936C/T polymorphisms in type 2 diabetes mellitus and diabetic nonproliferative retinopathy risk management.Ther Clin Risk Manag. 2015 Nov 27;11:1743-8. doi: 10.2147/TCRM.S93172. eCollection 2015. Ther Clin Risk Manag. 2015. PMID: 26664124 Free PMC article.
-
Clinical significance of serum vascular endothelial growth factor in young male asthma patients.Korean J Intern Med. 2017 Mar;32(2):295-301. doi: 10.3904/kjim.2014.242. Epub 2016 Mar 21. Korean J Intern Med. 2017. PMID: 26996348 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources